title: Brief postnatal exposure to phenobarbital impairs passive avoidance learning and sensorimotor gating in rats.
abstract: Phenobarbital is the most commonly utilized drug for the treatment of neonatal seizures. However, mounting preclinical evidence suggests that even brief exposure to phenobarbital in the neonatal period can induce neuronal apoptosis, alterations in synaptic development, and long-lasting changes in behavioral functions. In the present report, we treated neonatal rat pups with phenobarbital and evaluated behavior in adulthood. Pups were treated initially with a loading dose (80 mg/kg) on postnatal day (P)7 and with a lower dose (40 mg/kg) on P8 and P9. We examined sensorimotor gating (prepulse inhibition), passive avoidance, and conditioned place preference for cocaine when the animals reached adulthood. Consistent with our previous reports, we found that three days of neonatal exposure to phenobarbital significantly impaired prepulse inhibition compared with vehicle-exposed control animals. Using a step-though passive avoidance paradigm, we found that animals exposed to phenobarbital as neonates and tested as adults showed significant deficits in passive avoidance retention compared with matched controls, indicating impairment in associative memory and/or recall. Finally, we examined place preference conditioning in response to cocaine. Phenobarbital exposure did not alter the normal conditioned place preference associated with cocaine exposure. Our findings expand the profile of behavioral toxicity induced by phenobarbital.
authors.affiliation: Department of Pharmacology and Physiology, Georgetown University, School of Medicine, Washington, DC 20007, USA.
authors.forename: Samuel B
authors.initials: SB
authors.lastname: Gutherz
authors.affiliation: Department of Pharmacology and Physiology, Georgetown University, School of Medicine, Washington, DC 20007, USA.
authors.forename: Catherine V
authors.initials: CV
authors.lastname: Kulick
authors.affiliation: Department of Pharmacology and Physiology, Georgetown University, School of Medicine, Washington, DC 20007, USA.
authors.forename: Colin
authors.initials: C
authors.lastname: Soper
authors.affiliation: Department of Pharmacology and Physiology, Georgetown University, School of Medicine, Washington, DC 20007, USA; Interdisciplinary Program in Neuroscience, Georgetown University, School of Medicine, Washington, DC 20007, USA.
authors.forename: Alexei
authors.initials: A
authors.lastname: Kondratyev
authors.affiliation: Department of Pharmacology and Physiology, Georgetown University, School of Medicine, Washington, DC 20007, USA; Interdisciplinary Program in Neuroscience, Georgetown University, School of Medicine, Washington, DC 20007, USA.
authors.forename: Karen
authors.initials: K
authors.lastname: Gale
authors.affiliation: Department of Pharmacology and Physiology, Georgetown University, School of Medicine, Washington, DC 20007, USA; Interdisciplinary Program in Neuroscience, Georgetown University, School of Medicine, Washington, DC 20007, USA. Electronic address: paf22@georgetown.edu.
authors.forename: Patrick A
authors.initials: PA
authors.lastname: Forcelli
mesh_terms: D000818:Animals; D000927:Anticonvulsants / Q000633:toxicity*; D001362:Avoidance Learning / Q000187:drug effects*; D003042:Cocaine / Q000494:pharmacology*; D005260:Female; D008297:Male; D008568:Memory; D010634:Phenobarbital / Q000633:toxicity*; D051381:Rats; D012640:Seizures / Q000188:drug therapy*; D055139:Sensory Gating / Q000187:drug effects* / Q000502:physiology
chemical_list: D000927:Anticonvulsants; D003042:Cocaine; D010634:Phenobarbital
keywords: Antiepileptic drug; Behavior; Neonatal; Phenobarbital; Reward; Seizure; Toxicology
references.citation: Addict Biol. 2008 Mar;13(1):52-62
references.pmid: 17850417
references.citation: J Neurosci. 1999 Dec 15;19(24):RC48
references.pmid: 10594092
references.citation: BMJ. 2007 Jun 9;334(7605):1175-6
references.pmid: 17556434
references.citation: J Neurosci. 1992 Nov;12(11):4173-87
references.pmid: 1432095
references.citation: Neurology. 2005 Mar 8;64(5):776-7
references.pmid: 15753407
references.citation: Pediatr Res. 2010 May;67(5):532-7
references.pmid: 20098339
references.citation: Ann Neurol. 2012 Sep;72(3):363-72
references.pmid: 22581672
references.citation: Neuropharmacology. 2012 Jun;62(7):2337-45
references.pmid: 22366076
references.citation: Pediatr Neurol. 2003 Apr;28(4):277-80
references.pmid: 12849880
references.citation: N Engl J Med. 1990 Feb 8;322(6):364-9
references.pmid: 2242106
references.citation: Epilepsy Res. 1991 Nov-Dec;10(2-3):148-55
references.pmid: 1817955
references.citation: Bull World Health Organ. 2012 Dec 1;90(12):871-871A
references.pmid: 23284189
references.citation: Epilepsia. 2011 Dec;52(12):e207-11
references.pmid: 22050285
references.citation: Brain Res Bull. 1992 Jul;29(1):1-6
references.pmid: 1504846
references.citation: J Pharmacol Exp Ther. 2012 Mar;340(3):558-66
references.pmid: 22129597
references.citation: Epilepsia. 2004 Sep;45(9):1141-9
references.pmid: 15329080
references.citation: J Neurosci. 2000 Sep 15;20(18):7059-66
references.pmid: 10995852
references.citation: Brain Res. 1997 Oct 24;772(1-2):181-90
references.pmid: 9406971
references.citation: Behav Neurosci. 2012 Apr;126(2):290-300
references.pmid: 22250771
references.citation: Exp Neurol. 1990 May;108(2):176-87
references.pmid: 2335196
references.citation: Epilepsia. 2010 Jul;51 Suppl 3:18-23
references.pmid: 20618394
references.citation: Ann N Y Acad Sci. 2003 May;993:103-14; discussion 123-4
references.pmid: 12853301
references.citation: Early Hum Dev. 1979 Mar;3(1):79-83
references.pmid: 118862
references.citation: Epilepsia. 2011 Apr;52(4):794-801
references.pmid: 21371018
references.citation: Clin Pediatr (Phila). 1999 Jul;38(7):387-94
references.pmid: 10416094
references.citation: Pediatr Neurol. 2012 Feb;46(2):111-5
references.pmid: 22264706
references.citation: Psychopharmacology (Berl). 2001 Jul;156(2-3):194-215
references.pmid: 11549223
references.citation: Neurology. 1998 Jul;51(1):41-8
references.pmid: 9674776
references.citation: Int J Dev Neurosci. 1984;2(3):223-8
references.pmid: 24874036
references.citation: Ann Neurol. 2008 Oct;64(4):434-45
references.pmid: 18991352
references.citation: Arch Dis Child. 1982 Sep;57(9):653-7
references.pmid: 7125684
references.citation: Mol Cell Proteomics. 2008 Dec;7(12):2293-310
references.pmid: 18587059
references.citation: Epilepsia. 1992 Nov-Dec;33(6):987-93
references.pmid: 1464281
references.citation: Proc Natl Acad Sci U S A. 2002 Nov 12;99(23):15089-94
references.pmid: 12417760
references.citation: Behav Neural Biol. 1993 Mar;59(2):143-9
references.pmid: 8097395
references.citation: Croat Med J. 2010 Jun;51(3):215-8
references.pmid: 20564764
references.citation: Pediatr Neurol. 2007 Aug;37(2):85-90
references.pmid: 17675022
references.citation: Int J Dev Neurosci. 1985;3(3):223-7
references.pmid: 24874750